Edmonds Duncan Registered Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Edmonds Duncan Registered Investment Advisors, LLC

  • $446 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021
SELL
$59.34 - $66.74 $71,208 - $80,088
-1,200 Reduced 24.75%
3,649 $230,000
Q4 2020

Feb 19, 2021
SELL
$57.74 - $65.43 $57,740 - $65,430
-1,000 Reduced 17.1%
4,849 $296,000
Q4 2019

Jan 30, 2020
BUY
$49.21 - $64.19 $14,763 - $19,257
300 Added 5.41%
5,849 $375,000
Q2 2019

Aug 06, 2019
BUY
$44.62 - $49.34 $8,924 - $9,868
200 Added 3.74%
5,549 $256,000
Q2 2017

Aug 10, 2017
BUY
N/A
5,349
5,349 $298,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Edmonds Duncan Registered Investment Advisors, LLC Portfolio

Follow Edmonds Duncan Registered Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmonds Duncan Registered Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edmonds Duncan Registered Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email